Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA launches new priority review voucher program for select biopharmas
Sean Harper
Biotech
Horizon alums unveil Acelyrin to accelerate promising drugs
Acelyrin launches with series A financing from Sean Harper and Beth Seidenberg’s VC firm, Westlake Village BioPartners.
Amirah Al Idrus
Dec 15, 2020 4:45am
Harper, Seidenberg's Westlake reels in $500M across 2 funds
Dec 15, 2020 4:45am
Why Amgen vets Harper and Seidenberg set up their own VC shop
Feb 18, 2020 10:52am
Sean Harper and Beth Seidenberg unite to run $320M VC fund
Sep 5, 2018 7:00am
